Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
On Mar. 23, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
-
-
VCU researchers find explosive rise in tick-linked meat allergy across the U.S.
On Oct. 30, 2025, researchers at Virginia Commonwealth University and VCU Health announced preliminary study findings that show…
-
New virus uncovered in China – increased threat of tick-borne diseases
On Oct. 11, 2024, researchers in China published a study that provided details about a new wetland virus….
-
Biotechnology | CDC | Disease | Environmental
Emerging tick bite-associated meat allergy potentially affected thousands
On Jul. 27, 2023, the Centers for Disease Control and Prevention (CDC) reported that between 2010 and 2022,…
-
Economic burden of Lyme disease could be nearly $1 billion annually in the U.S.
On May 23, 2022, a study reports the economic burden of Lyme disease could be nearly $1 billion…
-
Valneva and Pfizer announced a collaboration to co-develop and commercialize Lyme disease vaccine
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine…
-
Lyme Bacterium Predates U.S. Lab That Conspiracy Theorists Say Unleashed Ticks on the Public
On Jul. 18, 2019, the U.S. House of Representatives last week voted to order the Department of Defense…
-
Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes
On Aug. 28, 2017, a team of researchers led by the Yale School of Public Health announced they…
